Brella SweatControl Patch

2023: Product Announcement

In mid-April 2023, Candesant Biomedical launched the Brella SweatControl Patch, a smart patch that is designed to reduce excessive underarm sweating for months after several minutes of wearing.

The Brella SweatControl Patch is designed to serve as an alternative, non-invasive solution to excessive sweating, which is being treated with prescription antiperspirants, wipes and creams for April 2023. The ailment is also treated with medications used to block nerves, antidepressants and repeated Botox injections.

Brella SweetControl Patch

The Brella SweatControl Patch sodium patch has been approved for the treatment of adults with primary axillary hyperhidrosis, a condition that causes excessive underarm sweating that is not always associated with heat or exercise. According to estimates, FDA about 15 million Americans claim hyperhidrosis as of April 2023, in fact, this condition can be much more common, since it is often not reported, and therefore it is not diagnosed.

FDA approval will allow the patch to become available to millions of people who face the physical, emotional, financial and aesthetic consequences of hyperhidrosis, or sweating beyond what is needed to cool the body, Candesant founder and CEO Nicketta Hunt said. Satisfaction with existing treatments is low, and 80% of consumers are looking for new treatments for excessive underarm sweating, Hunt said. Candesant's Brella SweatControl Patch offers a new treatment option for a common condition that limits activity, gets clothes dirty, causes frustration and embarrassment, undermines self-confidence and has not received adequate treatment for too long.

The launch of the Brella SweatControl Patch in will USA begin in late summer 2023, when Candesant will offer it to aesthetic practices in certain regions of the country as part of an early experience program. After that, the patch will be distributed nationwide, according to a statement from Candesant.

Doctors stick an adhesive plaster on patients' armpits for three minutes during a clinic visit. The procedures are based on a technology that Candesant calls targeted alkaline thermolysis (CST). According to the developers, since heat is released when sodium comes into contact with water, when water contained in droplets of sweat enters the sodium patch, a surge of thermal energy occurs as a result of the chemical reaction. This energy is then directed back to the ducts from which sweat has been released, causing microthermal trauma to the sweat ducts in order to deactivate the sweat glands for several weeks.^[1]

Notes